G Protein News and Research

RSS

"Mechanistic basis for understanding why we treat symptoms"

In the 1990s, the notion of "six degrees of separation" emphasized human linkages that connected people around the world.

9 Jun 2006

Potentially ground-breaking treatment for nerve damage caused by diabetes

The University of Manchester team has discovered that injection of a novel therapeutic that works by stimulating a person's genes may prevent nerve damage - primarily to the hands and feet - caused by the disease.

From The University of Manchester 8 Jun 2006

Nventa granted European patent covering heat shock protein fusion to treat influenza

Nventa Biopharmaceuticals Corporation announced that the European Patent Office has granted Patent Number EP 941,315 to Nventa.

8 Jun 2006

Glivec the best news yet for cancer victims

In what is great news for those suffering from chronic myeloid leukaemia (CML), the drug Glivec looks like being one of the biggest breakthroughs in cancer therapy for a years.

7 Jun 2006

Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose

One of the body's basic survival mechanisms is the neural machinery that triggers the hungry brain to the alertness needed for seeking food.

From The University of Manchester 7 Jun 2006

Scientists describe elaborate system of gene control triggered by chemical damage to DNA

Scientists describe for the first time a web of inter-related responses that cells use to avoid becoming diseased or cancerous after being exposed to a powerful mutagen.

7 Jun 2006

Trastuzumab results promising for HER-2 positive breast cancer patients

Researchers have shown that patients who receive trastuzumab at the same time as post-chemotherapy radiation treatments for HER-2 positive breast cancer have no more risk for major side effects or complications than those who do not receive the drug.

7 Jun 2006

Gardenia fruit compound helps treat the symptoms of type 2 diabetes

A Gardenia fruit extract traditionally used in Chinese medicine to treat the symptoms of type 2 diabetes does indeed contain a chemical that reverses some of the pancreatic dysfunctions that underlie the disease, researchers report in Cell Metabolism.

6 Jun 2006

Calpain protein key to preventing or promoting cell death

A protein called calpain can be the key either preventing or promoting the cell death, a Queen's University study has found.

6 Jun 2006

New human genotype may be prone to vCJD

A small study in the British Medical Journal suggests a new human genotype may be prone to variant Creutzfeldt-Jakob disease (vCJD).

6 Jun 2006

New procedures to help decide which breast cancer patients will benefit most from radiotherapy

New procedures which will help doctors decide which breast cancer patients will benefit most from radiotherapy begin trials this week.

6 Jun 2006

Researchers increase bone mass by tweaking the shape of a regulatory protein

Howard Hughes Medical Institute (HHMI) researchers at Stanford University have found that they can increase bone mass in mice by tweaking the shape of a regulatory protein.

6 Jun 2006

New findings offer hope for vaccine against AIDS

AIDS patients' failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought.

6 Jun 2006

New research on brain, hormones and behavior

New clinical and basic science research findings focusing on the interaction between hormones and the brain and its influence on behavior will be presented for the first time at the 6th International Congress of Neuroendocrinology.

6 Jun 2006

Maternal vitamin D levels and infant bone density

Can bones remember? According to new research presented at the IOF World Congress on Osteoporosis in Toronto, Canada they can.

6 Jun 2006

Type 1 diabetes results from selective destruction of pancreatic islet beta cells

IDDM, which used to be referred to as Type 1 diabetes, results from selective destruction of insulin-producing pancreatic islet beta cells by the body's immune system.

6 Jun 2006

PSA test alone not an ideal predictor of prostate cancer

Recent studies suggest that testing blood for prostate specific antigen (PSA) alone does not produce an ideal predictor of prostate cancer, and emerging data suggest this is especially true for obese men.

6 Jun 2006